A Phase 1b, Multi-center, Randomized, Double blind, Placebo-controlled Study to Investigate the Efficacy, Safety and Pharmacokinetics of CSL312 in the Prevention of Peripherally Inserted Central Catheter (PICC)-associated Thrombosis in Subjects with Cancer

  • Tran, Huyen (Primary Chief Investigator (PCI))
  • Chunilal, Sanjeev (Chief Investigator (CI))
  • Casey, John (Chief Investigator (CI))
  • Sanmugarajah, Jasotha (Chief Investigator (CI))
  • Kennedy, Nola (Project Manager)

Project: Research

Project Details

Effective start/end date10/02/2031/12/25


  • Thrombosis
  • Malignant Haematology
  • Clinical trial